Horvath Susan 4
4 · Sun BioPharma, Inc. · Filed Jul 2, 2019
Insider Transaction Report
Form 4
Horvath Susan
V.P. of Finance & CFO
Transactions
- Conversion
Convertible Promissory Note
2019-06-30−23,625→ 0 totalExercise: $3.50From: 2018-12-31Exp: 2019-06-30→ Common Stock (7,084 underlying) - Conversion
Common Stock
2019-06-30+7,084→ 7,084 total
Footnotes (1)
- [F1]All amounts due under the note automatically converted into shares of common stock of the Issuer based on conversion price of $3.50 per shares upon maturity.